Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2026

Conditions

Pruritis

Interventions

DRUG

Dupilumab

injection every two weeks while on study

OTHER

Placebo

injection every two weeks while on study

Trial Locations (1)

RECRUITING

Akron Children's Hospital, Akron

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

collaborator

Ohio State University

OTHER

lead

Akron Children's Hospital

OTHER